Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1071 | 1115 | 1296 | 903 | 1573 | 2349 |
Fund Return | 7.11% | 11.48% | 29.63% | -3.33% | 9.48% | 8.91% |
Place in category | 983 | 1441 | 753 | 1934 | 940 | 276 |
% in Category | 32 | 48 | 27 | 88 | 54 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Robeco BP US Premium Equities I $ | 5.13B | 4.06 | 10.16 | 9.34 | ||
Robeco BP US Premium Equities K $ | 5.13B | 4.06 | 10.16 | 9.34 | ||
Robeco BP US Premium Equities F $ | 5.13B | 2.47 | 5.91 | 8.96 | ||
LU0226953718 | 5.13B | -1.43 | 12.22 | 7.39 | ||
R BP Global Premium Equities Du | 4.52B | 2.03 | 7.87 | 6.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fundu | 13.85B | 4.41 | 1.82 | 10.03 | ||
Cap Group New Perspective lux A7 | 13.85B | 4.41 | 1.93 | - | ||
Capital Group New Perspective Funbu | 13.85B | 4.06 | 0.81 | 8.96 | ||
Cap Group New Perspective lux ZLd | 13.85B | 4.39 | 1.79 | 10.00 | ||
Capital Group New Perspective Funzu | 13.85B | 4.30 | 1.56 | 9.83 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 5.12 | 1,096.33 | -0.82% | |
Visa A | US92826C8394 | 4.97 | 272.46 | +0.43% | |
Amazon.com | US0231351067 | 4.66 | 176.44 | -1.60% | |
Microsoft | US5949181045 | 4.32 | 415.13 | +0.23% | |
Novo Nordisk B | DK0062498333 | 3.92 | 927.3 | +1.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Neutral | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review